PREMATURE BIRTH AND DISEASE PROGRAMMING. CONTRIBUTION OF NEONATAL INTENSIVE CARE
https://doi.org/10.15690/vsp.v13i5.1146
Abstract
Modern clinical practice for the care of the prematurely born infants has markedly improved their rates of survival. Since the clinical follow-up is of short duration, only limited data are available to relate diseases in adult life to events and interventions in the neonatal period. The major factors that could have a programming (which could lead to disease) effect include: 1) intrauterine growth restriction; 2) interruption of pregnancy with change in oxygenation and water environment; 3) nutritional and pharmacological protocols for clinical care. The available clinical and experimental data are discussed in the context of perturbations in DNA methylation and its possible programming effects. The consequences of antenatal and postnatal administration of glucocorticoids are discussed. We speculate that premature interruption of pregnancy and neonatal interventions by affecting DNA methylation may cause programming effects on the immature baby.
About the Authors
O. P. Kovtun
Ural State Medical University, Yekaterinburg
Russian Federation
Russian Federation
P. B. Tsyv'yan
Ural State Medical University, Yekaterinburg;
Mother and Child Care Research Institute, Yekaterinburg;
Institute of Immunology and Physiology, Yekaterinburg
Russian Federation
Russian Federation
References
1. Eichenwald E. C., Stark A. R. N. Engl. J. Med. 2008; 358 (9): 1700–1711.
2. Fanaroff A. A., Hack M., Walsh M. C. Semin. Perinatol. 2003; 27: 281–287.
3. Кулаков В. И., Антонов А. Г., Байбарина Е. Н. Российский вестник перинатологии и педиатрии. 2006; 4: 8–11.
4. Володин Н. Н., Дегтярев Д. Н. Вопросы акушерства, гинекологии и перинатологии. 2003; 2: 11–15.
5. Hack M. J. Dev. Behav. Pediatr. 2009; 30: 460–470. 6. Wilson-Costello D., Friedman H., Minich N., Fanaroff A. A., Hack M. Pediatrics. 2005; 115: 997–1003.
6. Barker D. J., Osmond C. Lancet 1986; 1: 1077–1081.
7. Gluckman P. D., Hanson M. A., Spencer H. G., Bateson P. Proc. Royal Soc. Lond. B. 2005; 272 (6): 671–677.
8. Цывьян П. Б., Ковтун О. П. Успехи физиологических наук. 2008; 1: 68–75.
9. Doyle L. W., Anderson P. J. Pediatrics. 2010; 126: 342–351.
10. Eriksson J., Forsen T., Tuomilehto J., Osmond C., Barker D. Hypertension. 2000; 36: 790–794.
11. Warner M. J., Ozanne S. E. Biochem. J. 2010; 427: 333–347.
12. Simmons R. Trends Endocrinol. Metab. 2005; 16: 390–394.
13. Beall M. H., van den Wijngaard J. P., van Gemert M. J., Ross M. G. Placenta. 2007; 28 (8–9): 824–832.
14. Greenough A. Semin. Fetal Neonatal Med. 2009; 14 (6): 339–344.
15. Filippi L., Messeri A., Dani C. Biol Neonate. 2004; 85: 210–216.
16. Avery S. V. Biochem. J. 2011; 434: 201–210.
17. Kalhan S.C., Marczewski S. E. Rev. Endocr. Metab. Disord. 2012; 13: 109–119.
18. Kalhan S. C., Wilson-Costello D. J. Developmental. Orig. Health Dis. 2013; 4: 121–133.
19. Symonds M. E., Sebert S. P., Hyatt M. A., Budge H. Nat. Rev. Endocrinol. 2009; 5: 604–610. 21. Hay W. W., Thureen P. Pediatr. Neonatol. 2010; 51: 198–207.
20. Ehrenkranz R. A., Younes N., Lemons J. A. Pediatrics. 1999; 104: 280–289.
21. Hay W.W., Thureen P. J. J. Pediatr. 2006; 148: 291–294.
22. Jadhav P., Parimi P. S., Kalhan S. C. J. Parenter. Enteral Nutr. 2007; 31: 278–283.
23. Ibrahim H. M., Jeroudi M. A., Baier R. J., Dhanireddy R., Krouskop R. W. J. Perinatol. 2004; 24: 482–486.
24. te Braake F. W., van den Akker C. H., Wattimena D. J., Huijmans J. G., van Goudoever J. B. J. Pediatr. 2005; 147 (3): 457–461.
25. Stephens B. E., Walden R. V., Gargus R. A. Pediatrics. 2009; 123: 1337–1343.
26. Augustyniak R. A., Singh K., Zeldes D., Singh M., Rossi N. F. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010; 298: 1375–1382.
27. Kalhan S. C., Uppal S. O., Moorman J. L. J. Biol. Chem. 2011; 286: 5266–5277.
28. Embleton N. E., Pang N., Cooke R. J. Pediatrics. 2001; 107: 270–273.
29. Dinerstein A., Nieto R. M., Solana C. L. J. Perinatol. 2006; 26: 436–442.
30. Peeples J. M., Carlson S. E., Werkman S. H., Cooke R. J. Am. J. Clin. Nutr. 1991; 53: 1455–1459.
31. Greene H. L., Phillips B. L., Franck L. Pediatrics. 1987; 79: 894–900.
32. Shenai J. P., Chytil F., Stahlman M. T. Pediatr. Res. 1958; 19: 185–188.
33. Spears K., Cheney C., Zerzan J. Am. J. Clin. Nutr. 2004; 80: 1589–1594.
34. Shenai J. P., Kennedy K. A., Chytil F., Stahlman M. T. J. Pediatr. 1987; 111: 269–277.
35. Tyson J. E., Wright L. L., Oh W. N. Engl. J. Med. 1999; 340: 1962–1968.
36. Darlow B. A., Graham P. J. Cochr. Database Syst. Rev. 2011; 10: CD000501. DOI:10.1002/14651858.CD000501.pub3.
37. Ambalavanan N., Tyson J. E., Kennedy K. A. Pediatrics. 2005; 115: 249–254.
38. Lammer E. J., Chen D. T., Hoar R. M., Agnish N. D., Benke P. J., Braun J. T. N. Engl. J. Med. 1985; 313: 837–841.
39. Goldmuntz E., Emanuel B. S. Circ. Res. 1997; 80: 437–443.
40. Niederreither K., Dolle P. Nat. Genet. 2008; 9: 541–553.
41. Vermot J., Niederreither K., Garnier J. M., Chambon P., Dolle P. Proc. Natl. Acad. Sci. USA. 2003; 100: 1763–1768.
42. Csaba G., Kovacs P., Pallinger E. Horm. Metab. Res. 2007; 39: 197–201.
43. Harris A., Seckl J. Horm. Behav. 2011; 59: 279–289.
44. Drake A. J., Tang J. I., Nyirenda M. J. Clin. Sci. (London). 2007; 113: 219–232. 47. Dessens A. B., Haas H. S., Koppe J. G. Pediatrics. 2000; 105: 77.
45. Finken M. J., Keijzer-Veen M. G., Dekker F. W. Arch. Dis. Child Fetal Neonatal Ed. 2008; 93: 442–447.
46. Doyle L. W., Ford G. W., Davis N. M., Callanan C. Clin. Sci. (London). 2000; 98: 137–142.
47. Dalziel S. R., Walker N. K., Parag V. Lancet. 2005; 365: 1856–1862.
48. Wapner R. J., Sorokin Y., Mele L. N. Engl. J. Med. 2007; 357: 1190–1198.
49. Stark A. R., Carlo W. A., Tyson J. E. N. Engl. J. Med. 2001; 344: 95–101.
50. Flier N. N., Barrington K. J. Cochr. Database Syst. Rev. 2006; CD000399.
51. Subhedar N., Dewhurst C. Arch. Dis. Child Fetal Neonatal Ed. 2007; 92: 337–341.
52. Donohue P. K., Gilmore M. M., Cristofalo E. Pediatrics. 2011; 127: 414–422.
53. Illi B., Colussi C., Grasselli A. Pharmacol. Ther. 2009; 123: 344–352.
54. Nott A., Riccio A. Cell Cycle. 2009; 8: 725–730.
Review
For citations:
Kovtun O.P., Tsyv'yan P.B. PREMATURE BIRTH AND DISEASE PROGRAMMING. CONTRIBUTION OF NEONATAL INTENSIVE CARE. Current Pediatrics. 2014;13(5):26-30. (In Russ.) https://doi.org/10.15690/vsp.v13i5.1146
Views:
807
Email this article 
